High-end diagnostics changing the face of medical testing industry
Last
month, Strand Life Sciences, a Bengaluru-based specialty diagnostic company,
bought the India operations of US-based medical diagnostic company, Quest
Diagnostic. The takeover created ripples in the medical
diagnostic industry in India.
Quest
had set shop some ten years ago and has an established routine testing business
with many corporate clients. Strand is actually a spinoff from IISc Bangalore
as a bioinformatics company. It bought out HCG’s diagnostic business in
January, with a focus on oncology testing and now with Quest, it is emerging as
a sophisticated end-to-end operator. The Quest acquisition offers a new service
line, of routine testing, which is 80-90 per cent of the diagnostic market. The
deal could make Strand a leader in the testing business.
“Quest's
corporate wellness testing and women
health segments are stronger than ours. Our oncology, advanced
diagnostics and genomics are stronger. Quest was stronger in the north, we are
strong in the south. We have a distributed presence in small towns in India,
especially in the south and west. Their presence in Delhi and Ghaziabad will be
complementary,” Says Ramesh Hariharan, CEO and Founder, Strand Life Science. Read
More
Comments
Post a Comment